Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, Status and Forecast 2020-2026
Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.
SNP genotyping is the simplest form of DNA variation among individuals. These simple changes can be of transition or transversion type and they occur throughout the genome at a frequency of about one in 1,000 bp. In the whole SNP genotyping industry, only a few companies can provide SNP genotyping platform while SNP genotyping service provider are located widely in the world.
SNP genotyping has various genotyping methods, such as TaqMan probe method, SNaPshot method, .MassArray method, .Illumina BeadXpress, HRM method and so on. Each method has its own characteristics. SNP genotyping will adopt an appropriate method according their customers’ specific demand or wanted results.
Illumina, Affymetrix and Applied Biosystems are industry leaders. They can provide SNP genotyping platform, reagent and service to their clients. Besides, all of them have authorized companies around the word to use their platform to offer genotyping service to some countries. In fact, in the platform field, the industry is still highly monopolized for the time being.
We tend to believe that this industry still has a bright future, considering the current gene research. There is also no doubt that there are will be more and more companies to provide innovative SNP genotyping related products and service to customers in the next few years, promoting the industry to develop healthily.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Single Nucleotide Polymorphism (SNP) Genotyping market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Single Nucleotide Polymorphism (SNP) Genotyping industry.
Based on our recent survey, we have several different scenarios about the Single Nucleotide Polymorphism (SNP) Genotyping YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 11370 million in 2019. The market size of Single Nucleotide Polymorphism (SNP) Genotyping will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Single Nucleotide Polymorphism (SNP) Genotyping market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Single Nucleotide Polymorphism (SNP) Genotyping market in terms of revenue.
Players, stakeholders, and other participants in the global Single Nucleotide Polymorphism (SNP) Genotyping market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Single Nucleotide Polymorphism (SNP) Genotyping market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Single Nucleotide Polymorphism (SNP) Genotyping market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Single Nucleotide Polymorphism (SNP) Genotyping market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Single Nucleotide Polymorphism (SNP) Genotyping market.
The following players are covered in this report:
SNP genotyping is the simplest form of DNA variation among individuals. These simple changes can be of transition or transversion type and they occur throughout the genome at a frequency of about one in 1,000 bp. In the whole SNP genotyping industry, only a few companies can provide SNP genotyping platform while SNP genotyping service provider are located widely in the world.
SNP genotyping has various genotyping methods, such as TaqMan probe method, SNaPshot method, .MassArray method, .Illumina BeadXpress, HRM method and so on. Each method has its own characteristics. SNP genotyping will adopt an appropriate method according their customers’ specific demand or wanted results.
Illumina, Affymetrix and Applied Biosystems are industry leaders. They can provide SNP genotyping platform, reagent and service to their clients. Besides, all of them have authorized companies around the word to use their platform to offer genotyping service to some countries. In fact, in the platform field, the industry is still highly monopolized for the time being.
We tend to believe that this industry still has a bright future, considering the current gene research. There is also no doubt that there are will be more and more companies to provide innovative SNP genotyping related products and service to customers in the next few years, promoting the industry to develop healthily.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Single Nucleotide Polymorphism (SNP) Genotyping market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Single Nucleotide Polymorphism (SNP) Genotyping industry.
Based on our recent survey, we have several different scenarios about the Single Nucleotide Polymorphism (SNP) Genotyping YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 11370 million in 2019. The market size of Single Nucleotide Polymorphism (SNP) Genotyping will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Single Nucleotide Polymorphism (SNP) Genotyping market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Single Nucleotide Polymorphism (SNP) Genotyping market in terms of revenue.
Players, stakeholders, and other participants in the global Single Nucleotide Polymorphism (SNP) Genotyping market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Single Nucleotide Polymorphism (SNP) Genotyping market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Single Nucleotide Polymorphism (SNP) Genotyping market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Single Nucleotide Polymorphism (SNP) Genotyping market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Single Nucleotide Polymorphism (SNP) Genotyping market.
The following players are covered in this report:
- Illumina
- Affymetrix
- Applied Biosystems
- Agilent Technologies
- Beckman Coulter
- Roche
- Qiagen
- Luminex Corporation
- Enzo Life Sciences
- Bio-rad
- Sequenom
- Ocimum Biosolutions
- GE Healthcare
- GenScript
- Douglas Scientific
- BGI
- Beijing Sunbiotech
- HuaGene Biotech
- Generay Biotech
- Benegene
- Shanghai Biochip
- GENESKY
- HD Biosciences
- Transversion
- Transition
- Diagnostics
- Animal
- Plant
- Research
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Single Nucleotide Polymorphism (SNP) Genotyping Revenue
1.4 Market Analysis by Type
1.4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Transversion
1.4.3 Transition
1.5 Market by Application
1.5.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application: 2020 VS 2026
1.5.2 Diagnostics
1.5.3 Animal
1.5.4 Plant
1.5.5 Research
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Single Nucleotide Polymorphism (SNP) Genotyping Industry Impact
1.6.1 How the Covid-19 is Affecting the Single Nucleotide Polymorphism (SNP) Genotyping Industry
1.6.1.1 Single Nucleotide Polymorphism (SNP) Genotyping Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Single Nucleotide Polymorphism (SNP) Genotyping Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Single Nucleotide Polymorphism (SNP) Genotyping Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Single Nucleotide Polymorphism (SNP) Genotyping Market Perspective (2015-2026)
2.2 Single Nucleotide Polymorphism (SNP) Genotyping Growth Trends by Regions
2.2.1 Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Share by Regions (2015-2020)
2.2.3 Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Strategy
2.3.6 Primary Interviews with Key Single Nucleotide Polymorphism (SNP) Genotyping Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Market Size
3.1.1 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Revenue (2015-2020)
3.1.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Players (2015-2020)
3.1.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio
3.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Single Nucleotide Polymorphism (SNP) Genotyping Revenue in 2019
3.3 Single Nucleotide Polymorphism (SNP) Genotyping Key Players Head office and Area Served
3.4 Key Players Single Nucleotide Polymorphism (SNP) Genotyping Product Solution and Service
3.5 Date of Enter into Single Nucleotide Polymorphism (SNP) Genotyping Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Type (2015-2020)
4.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Type (2021-2026)
5 SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
5.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2020)
6.2 Single Nucleotide Polymorphism (SNP) Genotyping Key Players in North America (2019-2020)
6.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
6.4 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2020)
7.2 Single Nucleotide Polymorphism (SNP) Genotyping Key Players in Europe (2019-2020)
7.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
7.4 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
8 CHINA
8.1 China Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2020)
8.2 Single Nucleotide Polymorphism (SNP) Genotyping Key Players in China (2019-2020)
8.3 China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
8.4 China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2020)
9.2 Single Nucleotide Polymorphism (SNP) Genotyping Key Players in Japan (2019-2020)
9.3 Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
9.4 Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2020)
10.2 Single Nucleotide Polymorphism (SNP) Genotyping Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
10.4 Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
11 INDIA
11.1 India Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2020)
11.2 Single Nucleotide Polymorphism (SNP) Genotyping Key Players in India (2019-2020)
11.3 India Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
11.4 India Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2020)
12.2 Single Nucleotide Polymorphism (SNP) Genotyping Key Players in Central & South America (2019-2020)
12.3 Central & South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
12.4 Central & South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Illumina
13.1.1 Illumina Company Details
13.1.2 Illumina Business Overview and Its Total Revenue
13.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.1.4 Illumina Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020))
13.1.5 Illumina Recent Development
13.2 Affymetrix
13.2.1 Affymetrix Company Details
13.2.2 Affymetrix Business Overview and Its Total Revenue
13.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.2.4 Affymetrix Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.2.5 Affymetrix Recent Development
13.3 Applied Biosystems
13.3.1 Applied Biosystems Company Details
13.3.2 Applied Biosystems Business Overview and Its Total Revenue
13.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.3.4 Applied Biosystems Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.3.5 Applied Biosystems Recent Development
13.4 Agilent Technologies
13.4.1 Agilent Technologies Company Details
13.4.2 Agilent Technologies Business Overview and Its Total Revenue
13.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.4.4 Agilent Technologies Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.4.5 Agilent Technologies Recent Development
13.5 Beckman Coulter
13.5.1 Beckman Coulter Company Details
13.5.2 Beckman Coulter Business Overview and Its Total Revenue
13.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.5.4 Beckman Coulter Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.5.5 Beckman Coulter Recent Development
13.6 Roche
13.6.1 Roche Company Details
13.6.2 Roche Business Overview and Its Total Revenue
13.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.6.4 Roche Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.6.5 Roche Recent Development
13.7 Qiagen
13.7.1 Qiagen Company Details
13.7.2 Qiagen Business Overview and Its Total Revenue
13.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.7.4 Qiagen Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.7.5 Qiagen Recent Development
13.8 Luminex Corporation
13.8.1 Luminex Corporation Company Details
13.8.2 Luminex Corporation Business Overview and Its Total Revenue
13.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.8.4 Luminex Corporation Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.8.5 Luminex Corporation Recent Development
13.9 Enzo Life Sciences
13.9.1 Enzo Life Sciences Company Details
13.9.2 Enzo Life Sciences Business Overview and Its Total Revenue
13.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.9.4 Enzo Life Sciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.9.5 Enzo Life Sciences Recent Development
13.10 Bio-rad
13.10.1 Bio-rad Company Details
13.10.2 Bio-rad Business Overview and Its Total Revenue
13.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.10.4 Bio-rad Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.10.5 Bio-rad Recent Development
13.11 Sequenom
10.11.1 Sequenom Company Details
10.11.2 Sequenom Business Overview and Its Total Revenue
10.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.11.4 Sequenom Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.11.5 Sequenom Recent Development
13.12 Ocimum Biosolutions
10.12.1 Ocimum Biosolutions Company Details
10.12.2 Ocimum Biosolutions Business Overview and Its Total Revenue
10.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.12.4 Ocimum Biosolutions Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.12.5 Ocimum Biosolutions Recent Development
13.13 GE Healthcare
10.13.1 GE Healthcare Company Details
10.13.2 GE Healthcare Business Overview and Its Total Revenue
10.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.13.4 GE Healthcare Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.13.5 GE Healthcare Recent Development
13.14 GenScript
10.14.1 GenScript Company Details
10.14.2 GenScript Business Overview and Its Total Revenue
10.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.14.4 GenScript Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.14.5 GenScript Recent Development
13.15 Douglas Scientific
10.15.1 Douglas Scientific Company Details
10.15.2 Douglas Scientific Business Overview and Its Total Revenue
10.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.15.4 Douglas Scientific Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.15.5 Douglas Scientific Recent Development
13.16 BGI
10.16.1 BGI Company Details
10.16.2 BGI Business Overview and Its Total Revenue
10.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.16.4 BGI Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.16.5 BGI Recent Development
13.17 Beijing Sunbiotech
10.17.1 Beijing Sunbiotech Company Details
10.17.2 Beijing Sunbiotech Business Overview and Its Total Revenue
10.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.17.4 Beijing Sunbiotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.17.5 Beijing Sunbiotech Recent Development
13.18 HuaGene Biotech
10.18.1 HuaGene Biotech Company Details
10.18.2 HuaGene Biotech Business Overview and Its Total Revenue
10.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.18.4 HuaGene Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.18.5 HuaGene Biotech Recent Development
13.19 Generay Biotech
10.19.1 Generay Biotech Company Details
10.19.2 Generay Biotech Business Overview and Its Total Revenue
10.19.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.19.4 Generay Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.19.5 Generay Biotech Recent Development
13.20 Benegene
10.20.1 Benegene Company Details
10.20.2 Benegene Business Overview and Its Total Revenue
10.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.20.4 Benegene Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.20.5 Benegene Recent Development
13.21 Shanghai Biochip
10.21.1 Shanghai Biochip Company Details
10.21.2 Shanghai Biochip Business Overview and Its Total Revenue
10.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.21.4 Shanghai Biochip Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.21.5 Shanghai Biochip Recent Development
13.22 GENESKY
10.22.1 GENESKY Company Details
10.22.2 GENESKY Business Overview and Its Total Revenue
10.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.22.4 GENESKY Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.22.5 GENESKY Recent Development
13.23 HD Biosciences
10.23.1 HD Biosciences Company Details
10.23.2 HD Biosciences Business Overview and Its Total Revenue
10.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.23.4 HD Biosciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.23.5 HD Biosciences Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Single Nucleotide Polymorphism (SNP) Genotyping Revenue
1.4 Market Analysis by Type
1.4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Transversion
1.4.3 Transition
1.5 Market by Application
1.5.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application: 2020 VS 2026
1.5.2 Diagnostics
1.5.3 Animal
1.5.4 Plant
1.5.5 Research
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Single Nucleotide Polymorphism (SNP) Genotyping Industry Impact
1.6.1 How the Covid-19 is Affecting the Single Nucleotide Polymorphism (SNP) Genotyping Industry
1.6.1.1 Single Nucleotide Polymorphism (SNP) Genotyping Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Single Nucleotide Polymorphism (SNP) Genotyping Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Single Nucleotide Polymorphism (SNP) Genotyping Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Single Nucleotide Polymorphism (SNP) Genotyping Market Perspective (2015-2026)
2.2 Single Nucleotide Polymorphism (SNP) Genotyping Growth Trends by Regions
2.2.1 Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Share by Regions (2015-2020)
2.2.3 Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Strategy
2.3.6 Primary Interviews with Key Single Nucleotide Polymorphism (SNP) Genotyping Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Market Size
3.1.1 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Revenue (2015-2020)
3.1.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Players (2015-2020)
3.1.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio
3.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Single Nucleotide Polymorphism (SNP) Genotyping Revenue in 2019
3.3 Single Nucleotide Polymorphism (SNP) Genotyping Key Players Head office and Area Served
3.4 Key Players Single Nucleotide Polymorphism (SNP) Genotyping Product Solution and Service
3.5 Date of Enter into Single Nucleotide Polymorphism (SNP) Genotyping Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Type (2015-2020)
4.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Type (2021-2026)
5 SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
5.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2020)
6.2 Single Nucleotide Polymorphism (SNP) Genotyping Key Players in North America (2019-2020)
6.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
6.4 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2020)
7.2 Single Nucleotide Polymorphism (SNP) Genotyping Key Players in Europe (2019-2020)
7.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
7.4 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
8 CHINA
8.1 China Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2020)
8.2 Single Nucleotide Polymorphism (SNP) Genotyping Key Players in China (2019-2020)
8.3 China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
8.4 China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2020)
9.2 Single Nucleotide Polymorphism (SNP) Genotyping Key Players in Japan (2019-2020)
9.3 Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
9.4 Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2020)
10.2 Single Nucleotide Polymorphism (SNP) Genotyping Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
10.4 Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
11 INDIA
11.1 India Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2020)
11.2 Single Nucleotide Polymorphism (SNP) Genotyping Key Players in India (2019-2020)
11.3 India Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
11.4 India Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2020)
12.2 Single Nucleotide Polymorphism (SNP) Genotyping Key Players in Central & South America (2019-2020)
12.3 Central & South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
12.4 Central & South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Illumina
13.1.1 Illumina Company Details
13.1.2 Illumina Business Overview and Its Total Revenue
13.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.1.4 Illumina Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020))
13.1.5 Illumina Recent Development
13.2 Affymetrix
13.2.1 Affymetrix Company Details
13.2.2 Affymetrix Business Overview and Its Total Revenue
13.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.2.4 Affymetrix Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.2.5 Affymetrix Recent Development
13.3 Applied Biosystems
13.3.1 Applied Biosystems Company Details
13.3.2 Applied Biosystems Business Overview and Its Total Revenue
13.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.3.4 Applied Biosystems Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.3.5 Applied Biosystems Recent Development
13.4 Agilent Technologies
13.4.1 Agilent Technologies Company Details
13.4.2 Agilent Technologies Business Overview and Its Total Revenue
13.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.4.4 Agilent Technologies Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.4.5 Agilent Technologies Recent Development
13.5 Beckman Coulter
13.5.1 Beckman Coulter Company Details
13.5.2 Beckman Coulter Business Overview and Its Total Revenue
13.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.5.4 Beckman Coulter Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.5.5 Beckman Coulter Recent Development
13.6 Roche
13.6.1 Roche Company Details
13.6.2 Roche Business Overview and Its Total Revenue
13.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.6.4 Roche Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.6.5 Roche Recent Development
13.7 Qiagen
13.7.1 Qiagen Company Details
13.7.2 Qiagen Business Overview and Its Total Revenue
13.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.7.4 Qiagen Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.7.5 Qiagen Recent Development
13.8 Luminex Corporation
13.8.1 Luminex Corporation Company Details
13.8.2 Luminex Corporation Business Overview and Its Total Revenue
13.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.8.4 Luminex Corporation Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.8.5 Luminex Corporation Recent Development
13.9 Enzo Life Sciences
13.9.1 Enzo Life Sciences Company Details
13.9.2 Enzo Life Sciences Business Overview and Its Total Revenue
13.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.9.4 Enzo Life Sciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.9.5 Enzo Life Sciences Recent Development
13.10 Bio-rad
13.10.1 Bio-rad Company Details
13.10.2 Bio-rad Business Overview and Its Total Revenue
13.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Introduction
13.10.4 Bio-rad Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
13.10.5 Bio-rad Recent Development
13.11 Sequenom
10.11.1 Sequenom Company Details
10.11.2 Sequenom Business Overview and Its Total Revenue
10.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.11.4 Sequenom Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.11.5 Sequenom Recent Development
13.12 Ocimum Biosolutions
10.12.1 Ocimum Biosolutions Company Details
10.12.2 Ocimum Biosolutions Business Overview and Its Total Revenue
10.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.12.4 Ocimum Biosolutions Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.12.5 Ocimum Biosolutions Recent Development
13.13 GE Healthcare
10.13.1 GE Healthcare Company Details
10.13.2 GE Healthcare Business Overview and Its Total Revenue
10.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.13.4 GE Healthcare Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.13.5 GE Healthcare Recent Development
13.14 GenScript
10.14.1 GenScript Company Details
10.14.2 GenScript Business Overview and Its Total Revenue
10.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.14.4 GenScript Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.14.5 GenScript Recent Development
13.15 Douglas Scientific
10.15.1 Douglas Scientific Company Details
10.15.2 Douglas Scientific Business Overview and Its Total Revenue
10.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.15.4 Douglas Scientific Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.15.5 Douglas Scientific Recent Development
13.16 BGI
10.16.1 BGI Company Details
10.16.2 BGI Business Overview and Its Total Revenue
10.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.16.4 BGI Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.16.5 BGI Recent Development
13.17 Beijing Sunbiotech
10.17.1 Beijing Sunbiotech Company Details
10.17.2 Beijing Sunbiotech Business Overview and Its Total Revenue
10.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.17.4 Beijing Sunbiotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.17.5 Beijing Sunbiotech Recent Development
13.18 HuaGene Biotech
10.18.1 HuaGene Biotech Company Details
10.18.2 HuaGene Biotech Business Overview and Its Total Revenue
10.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.18.4 HuaGene Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.18.5 HuaGene Biotech Recent Development
13.19 Generay Biotech
10.19.1 Generay Biotech Company Details
10.19.2 Generay Biotech Business Overview and Its Total Revenue
10.19.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.19.4 Generay Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.19.5 Generay Biotech Recent Development
13.20 Benegene
10.20.1 Benegene Company Details
10.20.2 Benegene Business Overview and Its Total Revenue
10.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.20.4 Benegene Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.20.5 Benegene Recent Development
13.21 Shanghai Biochip
10.21.1 Shanghai Biochip Company Details
10.21.2 Shanghai Biochip Business Overview and Its Total Revenue
10.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.21.4 Shanghai Biochip Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.21.5 Shanghai Biochip Recent Development
13.22 GENESKY
10.22.1 GENESKY Company Details
10.22.2 GENESKY Business Overview and Its Total Revenue
10.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.22.4 GENESKY Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.22.5 GENESKY Recent Development
13.23 HD Biosciences
10.23.1 HD Biosciences Company Details
10.23.2 HD Biosciences Business Overview and Its Total Revenue
10.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Introduction
10.23.4 HD Biosciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
10.23.5 HD Biosciences Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Single Nucleotide Polymorphism (SNP) Genotyping Key Market Segments
Table 2. Key Players Covered: Ranking by Single Nucleotide Polymorphism (SNP) Genotyping Revenue
Table 3. Ranking of Global Top Single Nucleotide Polymorphism (SNP) Genotyping Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Transversion
Table 6. Key Players of Transition
Table 7. COVID-19 Impact Global Market: (Four Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Single Nucleotide Polymorphism (SNP) Genotyping Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Single Nucleotide Polymorphism (SNP) Genotyping Players to Combat Covid-19 Impact
Table 12. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Regions (2015-2020)
Table 16. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Strategy
Table 22. Main Points Interviewed from Key Single Nucleotide Polymorphism (SNP) Genotyping Players
Table 23. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Players (2015-2020) (Million US$)
Table 24. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Players (2015-2020)
Table 25. Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Single Nucleotide Polymorphism (SNP) Genotyping as of 2019)
Table 26. Global Single Nucleotide Polymorphism (SNP) Genotyping by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Single Nucleotide Polymorphism (SNP) Genotyping Product Solution and Service
Table 29. Date of Enter into Single Nucleotide Polymorphism (SNP) Genotyping Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020) (Million US$)
Table 32. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Type (2015-2020)
Table 33. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2021-2026)
Table 34. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Application (2015-2020)
Table 35. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020) (Million US$)
Table 36. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Application (2021-2026)
Table 37. North America Key Players Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Single Nucleotide Polymorphism (SNP) Genotyping Market Share (2019-2020)
Table 39. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020) (Million US$)
Table 40. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2015-2020)
Table 41. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020) (Million US$)
Table 42. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2015-2020)
Table 43. Europe Key Players Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Single Nucleotide Polymorphism (SNP) Genotyping Market Share (2019-2020)
Table 45. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2015-2020)
Table 47. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2015-2020)
Table 49. China Key Players Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2019-2020) (Million US$)
Table 50. China Key Players Single Nucleotide Polymorphism (SNP) Genotyping Market Share (2019-2020)
Table 51. China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020) (Million US$)
Table 52. China Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2015-2020)
Table 53. China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020) (Million US$)
Table 54. China Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2015-2020)
Table 55. Japan Key Players Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Single Nucleotide Polymorphism (SNP) Genotyping Market Share (2019-2020)
Table 57. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2015-2020)
Table 59. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Single Nucleotide Polymorphism (SNP) Genotyping Market Share (2019-2020)
Table 63. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2015-2020)
Table 65. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2015-2020)
Table 67. India Key Players Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2019-2020) (Million US$)
Table 68. India Key Players Single Nucleotide Polymorphism (SNP) Genotyping Market Share (2019-2020)
Table 69. India Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020) (Million US$)
Table 70. India Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2015-2020)
Table 71. India Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020) (Million US$)
Table 72. India Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Single Nucleotide Polymorphism (SNP) Genotyping Market Share (2019-2020)
Table 75. Central & South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2015-2020)
Table 77. Central & South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2015-2020)
Table 79. Illumina Company Details
Table 80. Illumina Business Overview
Table 81. Illumina Product
Table 82. Illumina Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 83. Illumina Recent Development
Table 84. Affymetrix Company Details
Table 85. Affymetrix Business Overview
Table 86. Affymetrix Product
Table 87. Affymetrix Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 88. Affymetrix Recent Development
Table 89. Applied Biosystems Company Details
Table 90. Applied Biosystems Business Overview
Table 91. Applied Biosystems Product
Table 92. Applied Biosystems Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 93. Applied Biosystems Recent Development
Table 94. Agilent Technologies Company Details
Table 95. Agilent Technologies Business Overview
Table 96. Agilent Technologies Product
Table 97. Agilent Technologies Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 98. Agilent Technologies Recent Development
Table 99. Beckman Coulter Company Details
Table 100. Beckman Coulter Business Overview
Table 101. Beckman Coulter Product
Table 102. Beckman Coulter Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 103. Beckman Coulter Recent Development
Table 104. Roche Company Details
Table 105. Roche Business Overview
Table 106. Roche Product
Table 107. Roche Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 108. Roche Recent Development
Table 109. Qiagen Company Details
Table 110. Qiagen Business Overview
Table 111. Qiagen Product
Table 112. Qiagen Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 113. Qiagen Recent Development
Table 114. Luminex Corporation Business Overview
Table 115. Luminex Corporation Product
Table 116. Luminex Corporation Company Details
Table 117. Luminex Corporation Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 118. Luminex Corporation Recent Development
Table 119. Enzo Life Sciences Company Details
Table 120. Enzo Life Sciences Business Overview
Table 121. Enzo Life Sciences Product
Table 122. Enzo Life Sciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 123. Enzo Life Sciences Recent Development
Table 124. Bio-rad Company Details
Table 125. Bio-rad Business Overview
Table 126. Bio-rad Product
Table 127. Bio-rad Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 128. Bio-rad Recent Development
Table 129. Sequenom Company Details
Table 130. Sequenom Business Overview
Table 131. Sequenom Product
Table 132. Sequenom Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 133. Sequenom Recent Development
Table 134. Ocimum Biosolutions Company Details
Table 135. Ocimum Biosolutions Business Overview
Table 136. Ocimum Biosolutions Product
Table 137. Ocimum Biosolutions Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 138. Ocimum Biosolutions Recent Development
Table 139. GE Healthcare Company Details
Table 140. GE Healthcare Business Overview
Table 141. GE Healthcare Product
Table 142. GE Healthcare Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 143. GE Healthcare Recent Development
Table 144. GenScript Company Details
Table 145. GenScript Business Overview
Table 146. GenScript Product
Table 147. GenScript Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 148. GenScript Recent Development
Table 149. Douglas Scientific Company Details
Table 150. Douglas Scientific Business Overview
Table 151. Douglas Scientific Product
Table 152. Douglas Scientific Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 153. Douglas Scientific Recent Development
Table 154. BGI Company Details
Table 155. BGI Business Overview
Table 156. BGI Product
Table 157. BGI Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 158. BGI Recent Development
Table 159. Beijing Sunbiotech Company Details
Table 160. Beijing Sunbiotech Business Overview
Table 161. Beijing Sunbiotech Product
Table 162. Beijing Sunbiotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 163. Beijing Sunbiotech Recent Development
Table 164. HuaGene Biotech Company Details
Table 165. HuaGene Biotech Business Overview
Table 166. HuaGene Biotech Product
Table 167. HuaGene Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 168. HuaGene Biotech Recent Development
Table 169. Generay Biotech Company Details
Table 170. Generay Biotech Business Overview
Table 171. Generay Biotech Product
Table 172. Generay Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 173. Generay Biotech Recent Development
Table 174. Benegene Company Details
Table 175. Benegene Business Overview
Table 176. Benegene Product
Table 177. Benegene Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 178. Benegene Recent Development
Table 179. Shanghai Biochip Company Details
Table 180. Shanghai Biochip Business Overview
Table 181. Shanghai Biochip Product
Table 182. Shanghai Biochip Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 183. Shanghai Biochip Recent Development
Table 184. GENESKY Company Details
Table 185. GENESKY Business Overview
Table 186. GENESKY Product
Table 187. GENESKY Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 188. GENESKY Recent Development
Table 189. HD Biosciences Company Details
Table 190. HD Biosciences Business Overview
Table 191. HD Biosciences Product
Table 192. HD Biosciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 193. HD Biosciences Recent Development
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
Table 1. Single Nucleotide Polymorphism (SNP) Genotyping Key Market Segments
Table 2. Key Players Covered: Ranking by Single Nucleotide Polymorphism (SNP) Genotyping Revenue
Table 3. Ranking of Global Top Single Nucleotide Polymorphism (SNP) Genotyping Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Transversion
Table 6. Key Players of Transition
Table 7. COVID-19 Impact Global Market: (Four Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Single Nucleotide Polymorphism (SNP) Genotyping Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Single Nucleotide Polymorphism (SNP) Genotyping Players to Combat Covid-19 Impact
Table 12. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Regions (2015-2020)
Table 16. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Strategy
Table 22. Main Points Interviewed from Key Single Nucleotide Polymorphism (SNP) Genotyping Players
Table 23. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Players (2015-2020) (Million US$)
Table 24. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Players (2015-2020)
Table 25. Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Single Nucleotide Polymorphism (SNP) Genotyping as of 2019)
Table 26. Global Single Nucleotide Polymorphism (SNP) Genotyping by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Single Nucleotide Polymorphism (SNP) Genotyping Product Solution and Service
Table 29. Date of Enter into Single Nucleotide Polymorphism (SNP) Genotyping Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020) (Million US$)
Table 32. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Type (2015-2020)
Table 33. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2021-2026)
Table 34. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Application (2015-2020)
Table 35. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020) (Million US$)
Table 36. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Application (2021-2026)
Table 37. North America Key Players Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Single Nucleotide Polymorphism (SNP) Genotyping Market Share (2019-2020)
Table 39. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020) (Million US$)
Table 40. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2015-2020)
Table 41. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020) (Million US$)
Table 42. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2015-2020)
Table 43. Europe Key Players Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Single Nucleotide Polymorphism (SNP) Genotyping Market Share (2019-2020)
Table 45. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2015-2020)
Table 47. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2015-2020)
Table 49. China Key Players Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2019-2020) (Million US$)
Table 50. China Key Players Single Nucleotide Polymorphism (SNP) Genotyping Market Share (2019-2020)
Table 51. China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020) (Million US$)
Table 52. China Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2015-2020)
Table 53. China Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020) (Million US$)
Table 54. China Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2015-2020)
Table 55. Japan Key Players Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Single Nucleotide Polymorphism (SNP) Genotyping Market Share (2019-2020)
Table 57. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2015-2020)
Table 59. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Single Nucleotide Polymorphism (SNP) Genotyping Market Share (2019-2020)
Table 63. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2015-2020)
Table 65. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2015-2020)
Table 67. India Key Players Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2019-2020) (Million US$)
Table 68. India Key Players Single Nucleotide Polymorphism (SNP) Genotyping Market Share (2019-2020)
Table 69. India Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020) (Million US$)
Table 70. India Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2015-2020)
Table 71. India Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020) (Million US$)
Table 72. India Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Single Nucleotide Polymorphism (SNP) Genotyping Market Share (2019-2020)
Table 75. Central & South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2015-2020)
Table 77. Central & South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2015-2020)
Table 79. Illumina Company Details
Table 80. Illumina Business Overview
Table 81. Illumina Product
Table 82. Illumina Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 83. Illumina Recent Development
Table 84. Affymetrix Company Details
Table 85. Affymetrix Business Overview
Table 86. Affymetrix Product
Table 87. Affymetrix Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 88. Affymetrix Recent Development
Table 89. Applied Biosystems Company Details
Table 90. Applied Biosystems Business Overview
Table 91. Applied Biosystems Product
Table 92. Applied Biosystems Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 93. Applied Biosystems Recent Development
Table 94. Agilent Technologies Company Details
Table 95. Agilent Technologies Business Overview
Table 96. Agilent Technologies Product
Table 97. Agilent Technologies Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 98. Agilent Technologies Recent Development
Table 99. Beckman Coulter Company Details
Table 100. Beckman Coulter Business Overview
Table 101. Beckman Coulter Product
Table 102. Beckman Coulter Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 103. Beckman Coulter Recent Development
Table 104. Roche Company Details
Table 105. Roche Business Overview
Table 106. Roche Product
Table 107. Roche Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 108. Roche Recent Development
Table 109. Qiagen Company Details
Table 110. Qiagen Business Overview
Table 111. Qiagen Product
Table 112. Qiagen Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 113. Qiagen Recent Development
Table 114. Luminex Corporation Business Overview
Table 115. Luminex Corporation Product
Table 116. Luminex Corporation Company Details
Table 117. Luminex Corporation Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 118. Luminex Corporation Recent Development
Table 119. Enzo Life Sciences Company Details
Table 120. Enzo Life Sciences Business Overview
Table 121. Enzo Life Sciences Product
Table 122. Enzo Life Sciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 123. Enzo Life Sciences Recent Development
Table 124. Bio-rad Company Details
Table 125. Bio-rad Business Overview
Table 126. Bio-rad Product
Table 127. Bio-rad Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 128. Bio-rad Recent Development
Table 129. Sequenom Company Details
Table 130. Sequenom Business Overview
Table 131. Sequenom Product
Table 132. Sequenom Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 133. Sequenom Recent Development
Table 134. Ocimum Biosolutions Company Details
Table 135. Ocimum Biosolutions Business Overview
Table 136. Ocimum Biosolutions Product
Table 137. Ocimum Biosolutions Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 138. Ocimum Biosolutions Recent Development
Table 139. GE Healthcare Company Details
Table 140. GE Healthcare Business Overview
Table 141. GE Healthcare Product
Table 142. GE Healthcare Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 143. GE Healthcare Recent Development
Table 144. GenScript Company Details
Table 145. GenScript Business Overview
Table 146. GenScript Product
Table 147. GenScript Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 148. GenScript Recent Development
Table 149. Douglas Scientific Company Details
Table 150. Douglas Scientific Business Overview
Table 151. Douglas Scientific Product
Table 152. Douglas Scientific Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 153. Douglas Scientific Recent Development
Table 154. BGI Company Details
Table 155. BGI Business Overview
Table 156. BGI Product
Table 157. BGI Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 158. BGI Recent Development
Table 159. Beijing Sunbiotech Company Details
Table 160. Beijing Sunbiotech Business Overview
Table 161. Beijing Sunbiotech Product
Table 162. Beijing Sunbiotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 163. Beijing Sunbiotech Recent Development
Table 164. HuaGene Biotech Company Details
Table 165. HuaGene Biotech Business Overview
Table 166. HuaGene Biotech Product
Table 167. HuaGene Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 168. HuaGene Biotech Recent Development
Table 169. Generay Biotech Company Details
Table 170. Generay Biotech Business Overview
Table 171. Generay Biotech Product
Table 172. Generay Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 173. Generay Biotech Recent Development
Table 174. Benegene Company Details
Table 175. Benegene Business Overview
Table 176. Benegene Product
Table 177. Benegene Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 178. Benegene Recent Development
Table 179. Shanghai Biochip Company Details
Table 180. Shanghai Biochip Business Overview
Table 181. Shanghai Biochip Product
Table 182. Shanghai Biochip Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 183. Shanghai Biochip Recent Development
Table 184. GENESKY Company Details
Table 185. GENESKY Business Overview
Table 186. GENESKY Product
Table 187. GENESKY Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 188. GENESKY Recent Development
Table 189. HD Biosciences Company Details
Table 190. HD Biosciences Business Overview
Table 191. HD Biosciences Product
Table 192. HD Biosciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020) (Million US$)
Table 193. HD Biosciences Recent Development
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type: 2020 VS 2026
Figure 2. Transversion Features
Figure 3. Transition Features
Figure 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application: 2020 VS 2026
Figure 5. Diagnostics Case Studies
Figure 6. Animal Case Studies
Figure 7. Plant Case Studies
Figure 8. Research Case Studies
Figure 9. Others Case Studies
Figure 10. Single Nucleotide Polymorphism (SNP) Genotyping Report Years Considered
Figure 11. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Regions: 2020 VS 2026
Figure 13. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Players in 2019
Figure 16. Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Single Nucleotide Polymorphism (SNP) Genotyping as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Single Nucleotide Polymorphism (SNP) Genotyping Revenue in 2019
Figure 18. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Illumina Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 27. Affymetrix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Affymetrix Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 29. Applied Biosystems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Applied Biosystems Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 31. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Agilent Technologies Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 33. Beckman Coulter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Beckman Coulter Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 35. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Roche Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 37. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Qiagen Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 39. Luminex Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Luminex Corporation Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 41. Enzo Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Enzo Life Sciences Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 43. Bio-rad Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Bio-rad Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 45. Sequenom Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Sequenom Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 47. Ocimum Biosolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Ocimum Biosolutions Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 49. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. GE Healthcare Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 51. GenScript Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. GenScript Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 53. Douglas Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Douglas Scientific Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 55. BGI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. BGI Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 57. Beijing Sunbiotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Beijing Sunbiotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 59. HuaGene Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. HuaGene Biotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 61. Generay Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Generay Biotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 63. Benegene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Benegene Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Figure 1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type: 2020 VS 2026
Figure 2. Transversion Features
Figure 3. Transition Features
Figure 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application: 2020 VS 2026
Figure 5. Diagnostics Case Studies
Figure 6. Animal Case Studies
Figure 7. Plant Case Studies
Figure 8. Research Case Studies
Figure 9. Others Case Studies
Figure 10. Single Nucleotide Polymorphism (SNP) Genotyping Report Years Considered
Figure 11. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Regions: 2020 VS 2026
Figure 13. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Players in 2019
Figure 16. Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Single Nucleotide Polymorphism (SNP) Genotyping as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Single Nucleotide Polymorphism (SNP) Genotyping Revenue in 2019
Figure 18. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Illumina Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 27. Affymetrix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Affymetrix Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 29. Applied Biosystems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Applied Biosystems Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 31. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Agilent Technologies Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 33. Beckman Coulter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Beckman Coulter Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 35. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Roche Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 37. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Qiagen Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 39. Luminex Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Luminex Corporation Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 41. Enzo Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Enzo Life Sciences Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 43. Bio-rad Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Bio-rad Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 45. Sequenom Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Sequenom Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 47. Ocimum Biosolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Ocimum Biosolutions Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 49. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. GE Healthcare Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 51. GenScript Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. GenScript Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 53. Douglas Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Douglas Scientific Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 55. BGI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. BGI Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 57. Beijing Sunbiotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Beijing Sunbiotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 59. HuaGene Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. HuaGene Biotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 61. Generay Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Generay Biotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 63. Benegene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Benegene Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
